Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 14, 2026 | May 15, 2026 |
| RAYONIER ADVANCED MATERIALS INC.RYAM · Entity 5392 | Director | May 21, 2020 | May 21, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,316 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 1,544 · Balance 129,316 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
RAYONIER ADVANCED MATERIALS INC.
Report date May 21, 2020 · Filed May 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,450 |
Reported balance
After 2020-05-21 transaction · row 1
1 source rowRow 1 · 2020-05-21 · Exercise / conversion · Acquired 13,258 · Balance 108,450 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2020-05-21 | Direct | 0 |
Reported balance
After 2020-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-21 · Exercise / conversion · Disposed 13,258 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of RYAM common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,849 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,849 Underlying: Common Stock · 46,849 shares Expires 2013-02-25 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,844 | $0.00 Strike: $8.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,844 Underlying: Common Stock · 46,844 shares Expires 2012-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,846 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,846 Underlying: Common Stock · 46,846 shares Expires 2011-03-20 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 22,735 | $34.80 | $791,178.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,085 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 8,350 | $34.80 | $290,580.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.